BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹100 Cr | ₹74 Cr | ₹81 Cr | ₹-241 Cr | ₹-275 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹81 Cr |
| Mar2022 | ₹-241 Cr |
| Mar2021 | ₹-275 Cr |
How is Deferred Tax Assets / Liabilities of BIOCON Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 34.77 | |
| Mar2024 | ₹74 Cr | -8.17 | |
| Mar2023 | ₹81 Cr | Positive | |
| Mar2022 | ₹-241 Cr | Negative | |
| Mar2021 | ₹-275 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹69,466.0 Cr | 2.7% | 3.4% | 19.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 2.7% |
3.4% |
19.5% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses